EP3268031 - Bibliographic data

COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT

Last update 11/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

Active Biotech AB

Scheelevägen 22
223 63 Lund
Suède
(72) Inventors

José Amauri SOARES

49 Rue de Chatenay Bat Esterel 2
F-92160 Antony
France

Eric CHETAILLE

15 Rue de Neuilly
F-92110 Clichy
France

Jessica NAKHLE

IPSEN INNOVATION Z.I. de Courtaboeuf 5 avenue du Canada
91940 Les Ulis
France

Fabien SCHMIDLIN

4 Rue de la Mare La Padole
F-91590 Mondeville
France
(74) Agent

Mail recipient

Brann AB

P.O. Box 3690 Sveavägen 63
103 59 Stockholm
Suède

(21) Request number EP16705122.6
(22) Request date 16/02/2016

(11) Publication number EP3268031
Publication date 04/11/2020

(54) Title of the invention COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
(51) International classification A61K 31/4704A61K 39/395A61K 39/00A61K 45/06A61P 35/00C07K 16/28
International classification (before reform) None

Claimed priority

(31) Number: 15290069
(32) Date: 13/03/2015
(33) Country: EP

Initial application None
Divisional application None

Expected annuity Annuity: 6 - Amount: 120 € - Due date 01/03/2021
Surtax: 6 - Amount: 24 € - Due date 02/09/2021
Last annuity None

Publication None
History

Publication de la délivrance du brevet européen - Legal date 04/11/2020


Entrée en période de grâce du brevet d'invention - Legal date 02/03/2021


Déchéance du brevet d'invention après période de grâce - Legal date 01/03/2021